Exploratory clinical trial of the new 4th line Helicobacter pylori eradication therapy using vonopraza
Not Applicable
- Conditions
- Helicobacter infection with previous eradication failure
- Registration Number
- JPRN-UMIN000018836
- Lead Sponsor
- Department of Gastroenterology, The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnancy Lactation Allergy for the study drugs Severe major organ dysfunction Patients who are judged by the investigators to be inappropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication rate of Helicobacter pylori 8-12 wks after treatment
- Secondary Outcome Measures
Name Time Method Rate of adverse events